- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
182
Companies which are potentially undervalued and in an acceptable financial position.
182 companies
High Tide
Market Cap: CA$261.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.17
7D
9.1%
1Y
4.8%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.03
7D
-8.4%
1Y
69.9%
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.54
7D
2.4%
1Y
-14.4%
CorMedix
Market Cap: US$592.3m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.52
7D
2.3%
1Y
-37.6%
Kissei Pharmaceutical
Market Cap: JP¥161.9b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,905.00
7D
-9.9%
1Y
-13.2%
Innovent Biologics
Market Cap: HK$157.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$90.30
7D
0.7%
1Y
-7.9%
UCB
Market Cap: €42.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€223.30
7D
-10.8%
1Y
19.5%
Kuros Biosciences
Market Cap: CHF 906.0m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.96
7D
12.1%
1Y
-20.0%
Supernus Pharmaceuticals
Market Cap: US$2.5b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$43.25
7D
-7.1%
1Y
1.9%
Yunnan Baiyao GroupLtd
Market Cap: CN¥92.2b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.90
7D
-1.9%
1Y
-9.0%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩260,000.00
7D
13.3%
1Y
-24.0%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €193.4m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.22
7D
-0.2%
1Y
0.5%
Diaceutics
Market Cap: UK£122.3m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.45
7D
14.2%
1Y
5.1%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 179.30
7D
0.5%
1Y
-24.9%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$52.00
7D
0.5%
1Y
-29.8%
Ardelyx
Market Cap: US$1.2b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.01
7D
-1.5%
1Y
-2.3%
Dong-E-E-Jiao
Market Cap: CN¥34.8b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥54.25
7D
0.8%
1Y
5.8%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,749.00
7D
-10.5%
1Y
4.6%
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
29.4%
Journey Medical
Market Cap: US$178.1m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.40
7D
1.4%
1Y
-11.2%
Fennec Pharmaceuticals
Market Cap: US$333.1m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$10.11
7D
1.7%
1Y
23.7%
Amoy Diagnostics
Market Cap: CN¥6.8b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.72
7D
2.4%
1Y
-25.1%
Dong-A ST
Market Cap: ₩358.6b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩37,200.00
7D
10.7%
1Y
-15.1%
Perrigo
Market Cap: US$1.5b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$10.78
7D
4.7%
1Y
-59.5%
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€41.40
7D
-0.8%
1Y
24.1%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.95
7D
-1.2%
1Y
11.1%
China Resources Pharmaceutical Group
Market Cap: HK$30.5b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.85
7D
-1.1%
1Y
-8.2%
United Laboratories International Holdings
Market Cap: HK$18.0b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.13
7D
-0.7%
1Y
-37.9%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,500.00
7D
2.0%
1Y
-8.7%
Curaleaf Holdings
Market Cap: CA$3.3b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$12.64
7D
4.3%
1Y
61.4%
Avantor
Market Cap: US$9.2b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.68
7D
10.1%
1Y
17.5%
Madrigal Pharmaceuticals
Market Cap: US$11.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$507.56
7D
-5.8%
1Y
49.8%
Protara Therapeutics
Market Cap: US$224.8m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$4.01
7D
5.2%
1Y
28.9%
ACADIA Pharmaceuticals
Market Cap: US$4.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$27.15
7D
3.1%
1Y
14.1%
Pacira BioSciences
Market Cap: US$1.1b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$27.62
7D
4.6%
1Y
23.3%
Exelixis
Market Cap: US$13.8b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$56.00
7D
-0.9%
1Y
49.5%